Rocuronium Bromide Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 15, 2023. Reported reason: Delay in shipping of the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
65219-065-05
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)
Initial Posting
Feb 15, 2023

Reason

Delay in shipping of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.